The approval period for the active substance flumioxazine was extended.
Active Ingredients |
Limited until |
Reference |
Flumioxazin |
02/28/2037 |
COMMISSION IMPLEMENTING REGULATION (EU) 2022/43 of 13 January 2022 1) |
The lifetime extensions have no influence on the current maximum residue limits.
Due to a revised classification with regard to reproductive toxicity, the active substance is no longer classified as a candidate for substitution and is removed from the list of active substances to be substituted.
1)
Author: Dr. Frank Mörsberger